List of insiders holdings for Revance Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Eastman Ronald W Director 10% Owner | 2017-05-12 19:47:25 | 9,000 4,134,962 | 4,143,962 | Form 4 |
| 2 | NovaQuest Pharma Opportunities Fund III L.P. NQ HCIF General Partner L.P. NQ HCIF GP Ltd. 10% Owner | 2019-02-12 11:36:23 | 1,558,426 0 | 1,558,426 | Form 13G |
| 3 | Rankin Aubrey Director | 2022-03-17 17:50:59 | 94,091 475,913 | 570,004 | Form 4 |
| 4 | Sjuts Dustin S President | 2024-03-19 18:45:36 | 167,550 0 | 167,550 | Form 4 |
| 5 | Browne L Daniel CEO and President | 2019-07-02 21:15:20 | 153,193 409 | 153,602 | Form 4 |
| 6 | Joshi Abhay COO, President of R&D | 2022-03-17 17:56:18 | 120,708 0 | 120,708 | Form 4 |
| 7 | Zavodnick Todd Erik CCO & President, | 2018-10-17 18:53:25 | 96,407 0 | 96,407 | Form 4 |
| 8 | Ruegg Curtis EVP, Technical Operations | 2016-06-15 19:29:17 | 72,780 0 | 72,780 | Form 4 |
| 9 | SILVERNAIL LAUREN P CFO & CBO | 2018-05-24 19:24:06 | 65,497 0 | 65,497 | Form 4 |
| 10 | BYRNES ROBERT F Director | 2020-05-15 18:35:49 | 28,500 13,665 | 42,165 | Form 4 |
| 11 | Bertolino Arthur Peter EVP and Chief Medical Officer | 2015-11-17 21:45:14 | 34,001 0 | 34,001 | Form 4 |
| 12 | GARDNER PHYLLIS Director | 2020-05-15 18:39:52 | 28,500 0 | 28,500 | Form 4 |
| 13 | Waugh Jacob Chief Scientific Officer | 2015-05-21 19:08:41 | 28,413 0 | 28,413 | Form 4 |
| 14 | McDowell Caryn Gordon SVP, GC & Secretary | 2020-02-19 20:23:23 | 23,453 0 | 23,453 | Form 4 |
| 15 | Vickers Philip J. Director | 2022-05-13 18:13:27 | 10,756 0 | 10,756 | Form 4/A |
| 16 | Glasheen James Walter Director | 2016-05-09 19:14:14 | 8,000 0 | 8,000 | Form 4 |
| 17 | PRYGOCKI MARK A SR Director | 2016-05-09 19:12:25 | 8,000 0 | 8,000 | Form 4 |
| 18 | Tunnicliffe Jonathan Director 10% Owner | 2015-05-27 20:33:21 | 8,000 0 | 8,000 | Form 4/A |
| 19 | WOOTEN RONALD J Director 10% Owner | 2015-05-27 20:31:37 | 8,000 0 | 8,000 | Form 4/A |
| 20 | ESSEX WOODLANDS HEALTH VENTURES FUND VIII LP ESSEX WOODLANDS HEALTH VENTURES FUND VIII-A LP ESSEX WOODLANDS HEALTH VENTURES FUND VIII-B LP 10% Owner | 2014-04-10 17:45:13 | 0 8,000 | 8,000 | Form 4 |
| 21 | Allouche Cyril Principal Accounting Officer | 2019-03-19 20:58:46 | 6,400 0 | 6,400 | Form 4 |
| 22 | Gangolli Julian S Director | 2025-02-06 20:06:31 | 0 0 | 0 | Form 4 |
| 23 | Foley Mark J President & CEO | 2025-02-06 15:59:42 | 0 0 | 0 | Form 4 |
| 24 | Schilke Tobin CFO | 2025-02-06 15:59:07 | 0 0 | 0 | Form 4 |
| 25 | Moxie Dwight CLO & GC | 2025-02-06 15:58:43 | 0 0 | 0 | Form 4 |
| 26 | Hollander David CMO & Global Therapeutics Lead | 2025-02-06 15:58:01 | 0 0 | 0 | Form 4 |
| 27 | Jordan Erica Chief Commercial Officer | 2025-02-06 15:57:14 | 0 0 | 0 | Form 4 |
| 28 | Ware Olivia C Director | 2025-02-06 15:56:26 | 0 0 | 0 | Form 4 |
| 29 | Kolaja Carey OConnor Director | 2025-02-06 15:56:01 | 0 0 | 0 | Form 4 |
| 30 | Coric Vlad Director | 2025-02-06 15:49:44 | 0 0 | 0 | Form 4 |
| 31 | Beraud Jill Director | 2025-02-06 15:49:13 | 0 0 | 0 | Form 4 |
| 32 | Nolet Chris Director | 2025-02-06 15:48:44 | 0 0 | 0 | Form 4 |
| 33 | Russell Angus C. Director | 2025-02-06 15:45:31 | 0 0 | 0 | Form 4 |